Convalescent patients – Page 11 – Communicable Diseases Research

High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19

Clinical Medicine

Published on 2020-10-152022-10-30
Journal: JCI Insight [Category] COVID-19, MERS, SARS,

[키워드] Activation acute respiratory syndrome affecting alteration analyzed Anergy antibody CD4 CD8 Cellular immune response Characteristics characterized controls convalescent individuals Convalescent patients coronavirus coronavirus disease correlated Course COVID-19 COVID-19 patient cytokine disease severity ELISA expression functional IFN-γ IgA IgA antibody IgG IgG levels IL-2 Immunity immunoglobulins immunopathology lung lymphocyte lymphocyte subpopulation lymphopenia marker mounted Patient patient group peptide pool phenotypical plasmablast proliferation quantified Rolf SARS-CoV-2 SARS-CoV-2 specific T-cell severe disease Severity of disease significantly higher state subpopulations supported T cell T cells TNF-α uninfected uninfected control university viral replication
[DOI] 10.1172/jci.insight.142167 PMC 바로가기 [Article Type] Clinical Medicine

A simple protein-based surrogate neutralization assay for SARS-CoV-2

Research Article

Published on 2020-10-022022-10-30
Journal: JCI Insight [Category] COVID-19, MERS,

[키워드] ACE2 acute respiratory syndrome Adaptive immunity angiotensin-converting enzyme 2 antibody Antigen assays characterized Clinical outcome Cohort Convalescent patients Convalescent plasma therapy coronavirus detect ELISA humoral immune response immune correlate immunoglobulins Infection Infectious disease Interaction live SARS-CoV-2 MOST neutralization Neutralization assay neutralizing antibody Patient performed plaque reduction neutralization platform PRNT pseudotyped public health RBD receptor Receptor binding domain Safe SARS-CoV-2 SARS-COV-2 infection serum and plasma Spike protein Support the patient the RBD the SARS-CoV-2 treatment approaches Vaccination strategies virus while
[DOI] 10.1172/jci.insight.142362 PMC 바로가기 [Article Type] Research Article

Antibody tests for diagnosing COVID-19: how relevant are they?

COVID-19 진단을 위한 항체 검사: 얼마나 관련성이 있습니까?

Commentary

Published on 2020-09-082022-09-01
Journal: The Pan African Medical Journal [Category] MERS, 진단,

Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals

Article

Published on 2020-08-142022-10-04
Journal: Signal Transduction and Targeted Therapy [Category] Fulltext, MERS, 변종,

SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses

Article

Published on 2020-07-142022-10-04
Journal: Nature Communications [Category] SARS, 임상, 진단, 치료기술, 치료법,

The effect of massage on the quality of life in patients recovering from COVID-19 A systematic review protocol

4700

Published on 2020-06-052022-10-30
Journal: Medicine [Category] COVID-19,

Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2

Review

Published on 2020-05-202022-10-29
Journal: International Journal of Molecular Sciences [Category] COVID-19, MERS, SARS,

Clinical characteristics and plasma antibody titer of patients with COVID-19 in Zhejiang, China

중국 저장성 COVID-19 환자의 임상적 특성 및 혈장 항체가

Article

Published on 2020-01-012022-09-12
Journal: Journal of Zhejiang University. Science. B [Category] MERS, 진단,

[키워드] acute respiratory syndrome affected age anti-viral drug antibody Antibody titer Berry caused Characteristics China clinical Clinical characteristics common cold Convalescent patients convalescent plasma coronavirus Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 critically ill patients Donor effective Fatality rate female gastroenteritis Human humans IgG IgM immunization Immunoglobulin G improve clinical outcome increase Infection Infectious disease male Mild Neutralizing Neutralizing antibody titer offer patients with COVID-19 pilot study plasma antibody Pneumonia progression report reported SARS-CoV-2 severe COVID-19 severely ill patient shown the disease therapeutic efficacy therapeutic strategy therapy treating COVID-19 upper respiratory tract Vaccine Viremia WHO World Health Organization Zhejiang
[DOI] 10.1631/jzus.B2000593 PMC 바로가기 [Article Type] Article